Efficacy and safety of tislelizumab, an anti-PD-1 antibody, versus sorafenib as first-line treatment in patients with advanced hepatocellular carcinoma in a phase 3, randomized, open-label, multicenter study - Trial in progress

Abstract

of the toughest procedures for pancreatic surgeon is the resection of The procedure is accompanied by high morbidity and compliselection, advancements in perioperative care and in surgical ved perioperative mortality. The main goal of this study was to identify potential impact factors for perioperative morbidity and mortality as well as consequences of perioperative morbidity on long-term survival in pancreatic head resections. Methods: A retrospective study of clinical-pathological factors of 240 patients which were divided into two chronological groups (